Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

180 Life Sciences Corp (NQ: ATNF )

1.521 -0.069 (-4.33%)
Streaming Delayed Price Updated: 10:57 AM EDT, Jun 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about 180 Life Sciences Corp

< Previous 1 2 3 Next >
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Initiates Formal Discussions with UK and US Regulatory Authorities Following Promising Dupuytren’s Trial
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Report Positive Results of Dupuytren’s Disease Study
Via Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Scientific Advisory Board
Via Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Issues Letter to Shareholders from CEO Dr. James Woody
Via Investor Brand Network
Topics Regulatory Compliance
Exposures Legal Regulatory
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Participation in Biotech Showcase 2022 Virtual Conference
Via Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces License Agreement with University of Oxford
Via Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Releases Additional Info Regarding Successful Dupuytren Phase 2b Clinical Trial Results
Via Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Receives Grants of New Patents Through Licensing Agreement
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Co-Founder to Keynote at 2021 International Dupuytren Symposium
Via Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Strategic Appointment of Quan A. Vu
Via Investor Brand Network
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Releases Preclinical Report on the CBG Impact on Pain, Inflammation, Obesity
Via Investor Brand Network
Topics Cannabis Derivatives
Exposures Cannabis Derivatives
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Continues to Expand Portfolio, Pipeline and Patient Access to Innovative Therapies
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF), Celltrion Healthcare Enter MOU for Strategic Supply Agreement
Via Investor Brand Network
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.